A major advance in cancer investigation is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This crucial tumor inhibitor protein is frequently inactivated in many kinds of cancer, causing https://esocialmall.com/story7465341/vhh-fragments-reactivate-p53-new-promising-approach-for-tumor-management